Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Diazepam - Generic Drug Details

« Back to Dashboard

What are the generic sources for diazepam and what is the scope of diazepam freedom to operate?

is the generic ingredient in eight branded drugs marketed by Martec Usa Llc, Upsher-smith Labs, Ferndale Labs, Actavis Elizabeth, Ivax Sub Teva Pharms, West-ward Pharms Int, Warner Chilcott, Watson Labs, Parenta Pharms, Quantum Pharmics, Us Army, Mylan, Dava Pharms Inc, Lannett Holdings Inc, Mayne Pharma, Valeant Pharms North, Vintage Pharms, Barr, Teva Pharms, Halsey, Roxane, Abraxis Pharm, Virtus Pharms, Roche, Watson Labs Inc, Marsam Pharms Llc, Pioneer Pharms, Hospira, Pharmacia And Upjohn, and Duramed Pharms Barr, and is included in eighty-two NDAs. There is one patent protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for diazepam. Fifty-one suppliers are listed for this compound.

Summary for Generic Name: diazepam

Drug Master File Entries: see list8
Suppliers / Packagers: see list51
Bulk Api Vendors: see list47
Clinical Trials: see list28
Patent Applications: see list6,703
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diazepam at DailyMed

Pharmacology for Ingredient: diazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
INJECTABLE;INJECTION070911-001Aug 28, 1986DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL070996-001Aug 15, 1986DISCNNoNo► Subscribe► Subscribe
Quantum Pharmics
TABLET;ORAL072433-001Apr 29, 1988DISCNNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
TABLET;ORAL071307-001Dec 10, 1986ABRXNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
TABLET;ORAL070361-001Sep 4, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus